Allan Jonathan (CIK 1966716) reported 38 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-18). Recent activity: Sell STOK (1,457 shares), Sell STOK (8,692 shares), Sell STOK (601 shares), Sell STOK (72 shares), Sell STOK (2,476 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-18 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,457 | $43,637 |
| 2026-03-24 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 8,692 | $292,399 |
| 2026-03-24 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 601 | $20,680 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 72 | $2,365 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 2,476 | $81,064 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,791 | $59,784 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 4,222 | $132,064 |
| 2026-03-19 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 334 | $10,618 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 7,475 | $0 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 6,000 | $0 |
| 2026-03-17 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 12,000 | $0 |
| 2025-12-10 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 2,678 | $87,330 |
| 2025-12-10 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,300 | $41,080 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 6,000 | $0 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 824 | $25,346 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 194 | $6,076 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,004 | $31,455 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 5,437 | $168,982 |
| 2025-12-05 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 2,344 | $74,445 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 12,357 | $0 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,416 | $41,857 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 868 | $26,162 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 898 | $27,245 |
| 2025-12-03 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Sell | 1,394 | $43,005 |
| 2025-10-07 | Stoke Therapeutics, Inc. (STOK) | GENERAL COUNSEL & CORP SEC | Buy | 10,000 | $91,500 |
Source: SEC Form 4 filings · as of 2026-06-18